Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. (2017)

First Author: Ward M
Attributed to:  Mitochondrial oxidative damage and human diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.24479

Publication URI: https://www.repository.cam.ac.uk/handle/1810/277186

Type: Journal Article/Review